HC Biopharma Inc.
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors (NCT07477743) | HC Biopharma Inc. | 2026-03-17 |
| The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE (NCT07306585) | HC Biopharma Inc. | 2025-12-30 |
| HC010 in First-line PD-L1 Positive Advanced NSCLC Patients (NCT07169552) | HC Biopharma Inc. | 2025-12-09 |
| A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer (NCT07381829) | HC Biopharma Inc. | 2025-10-27 |
| Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects. (NCT06657703) | HC Biopharma Inc. | 2024-11-25 |
| A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors (NCT06307925) | HC Biopharma Inc. | 2024-03-27 |
| A Study of HC006 in Subjects With Advanced Solid Tumors (NCT06304571) | HC Biopharma Inc. | 2024-02-27 |
Track HC Biopharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.